ArticleCancer2023

Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms.

Raoul Tibes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.